BRIEF published on 10/21/2024 at 14:06, 1 year 3 months ago Mainz BioMed Releases Mid-Year 2024 Financial Results Financial Results FDA Feedback Mainz Biomed ColoAlert® Cancer Detection
BRIEF published on 10/21/2024 at 14:06, 1 year 3 months ago Mainz BioMed publie ses résultats financiers du premier semestre 2024 Résultats Financiers ColoAlert® Mayence Biomed Détection Du Cancer Commentaires De La FDA
PRESS RELEASE published on 10/21/2024 at 14:01, 1 year 3 months ago Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update Mainz Biomed reports 4% revenue increase in Mid-Year 2024 Financial Results with 32% decrease in loss from operations. Company highlights successful studies at ASCO and outlines strategic plan for 2025 Financial Results Corporate Update ColoAlert Mainz Biomed EAArly DETECT
BRIEF published on 10/08/2024 at 14:05, 1 year 3 months ago Mainz Biomed Sees Surge in Demand for Enhanced ColoAlert Screening Mainz Biomed Colorectal Cancer Screening Test Enhanced ColoAlert GANZIMMUN Diagnostics
BRIEF published on 10/08/2024 at 14:05, 1 year 3 months ago Mainz Biomed constate une augmentation de la demande pour le dépistage amélioré ColoAlert Cancer Colorectal Mayence Biomed Test De Dépistage ColoAlert Amélioré Diagnostic GANZIMMUN
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 3 months ago Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version Mainz Biomed reports increasing demand for enhanced ColoAlert product leading to transition by existing partners to new version, featuring at Medizinische Woche Baden-Baden ColoAlert Mainz Biomed Partners Demand Medizinische Woche
BRIEF published on 10/01/2024 at 14:06, 1 year 4 months ago Mainz Biomed's CEO Projects Substantial Growth and U.S. FDA Trials in 2025 Cancer Diagnostics Mainz Biomed CRC Screening FDA Trials Growth 2025
BRIEF published on 10/01/2024 at 14:06, 1 year 4 months ago Le PDG de Mainz Biomed prévoit une croissance substantielle et des essais cliniques auprès de la FDA américaine en 2025 Mayence Biomed Dépistage Du Cancer Colorectal Diagnostic Du Cancer Essais De La FDA Croissance 2025
PRESS RELEASE published on 10/01/2024 at 14:01, 1 year 4 months ago Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 Mainz Biomed CEO Guido Baechler shares plans for major growth and U.S. FDA trials in 2025, highlighting innovative cancer diagnostics and upcoming clinical developments Growth Cancer Diagnostics CEO Statement Mainz Biomed FDA Trials
BRIEF published on 09/18/2024 at 14:06, 1 year 4 months ago Mainz Biomed Announces Petra Smeltzer Starke as Brand Ambassador Cancer Screening Early Detection Brand Ambassador Biomed FDA Trial
Published on 02/05/2026 at 09:05, 3 hours ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 10 hours 30 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 12 hours 5 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 40 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 11:47, 18 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:45, 20 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:30, 35 minutes ago Linde Reports Full-Year and Fourth-Quarter 2025 Results (Earnings Release Tables Attached)
Published on 02/05/2026 at 11:30, 35 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 35 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 18 hours 1 minute ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 18 hours 20 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
